KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Bausch Health Companies (BHC) over the last 15 years, with Q3 2025 value amounting to $375.5 million.

  • Bausch Health Companies' Shares Outstanding (Diluted Average) rose 192.73% to $375.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $375.5 million, marking a year-over-year increase of 192.73%. This contributed to the annual value of $368.0 million for FY2024, which is 84.95% up from last year.
  • According to the latest figures from Q3 2025, Bausch Health Companies' Shares Outstanding (Diluted Average) is $375.5 million, which was up 192.73% from $373.5 million recorded in Q2 2025.
  • Over the past 5 years, Bausch Health Companies' Shares Outstanding (Diluted Average) peaked at $375.5 million during Q3 2025, and registered a low of $356.8 million during Q1 2021.
  • In the last 5 years, Bausch Health Companies' Shares Outstanding (Diluted Average) had a median value of $364.9 million in 2023 and averaged $365.3 million.
  • In the last 5 years, Bausch Health Companies' Shares Outstanding (Diluted Average) decreased by 8.24% in 2022 and then skyrocketed by 192.73% in 2025.
  • Over the past 5 years, Bausch Health Companies' Shares Outstanding (Diluted Average) (Quarter) stood at $358.9 million in 2021, then increased by 0.86% to $362.0 million in 2022, then increased by 0.8% to $364.9 million in 2023, then increased by 0.85% to $368.0 million in 2024, then grew by 2.04% to $375.5 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $375.5 million in Q3 2025, compared to $373.5 million in Q2 2025 and $369.6 million in Q1 2025.